Tom Gevers

1.1k total citations
13 papers, 847 citations indexed

About

Tom Gevers is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Tom Gevers has authored 13 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Tom Gevers's work include Tuberculosis Research and Epidemiology (7 papers), Respiratory viral infections research (6 papers) and Mycobacterium research and diagnosis (4 papers). Tom Gevers is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Respiratory viral infections research (6 papers) and Mycobacterium research and diagnosis (4 papers). Tom Gevers collaborates with scholars based in United States, Belgium and France. Tom Gevers's co-authors include Koen Andries, Nacer Lounis, Luc Vranckx, Anil Koul, Bouke C. de Jong, Nele Coeck, Cristina Villellas, Kim Thys, Rudy Willebrords and Frans Janssens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Tom Gevers

13 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom Gevers United States	12	624	611	222	119	102	13	847
Keira A. Cohen United States	17	511 0.8×	561 0.9×	283 1.3×	119 1.0×	83 0.8×	20	924
Catherine Raynaud France	8	433 0.7×	495 0.8×	281 1.3×	87 0.7×	56 0.5×	11	714
Firat Kaya United States	15	471 0.8×	688 1.1×	367 1.7×	168 1.4×	43 0.4×	30	947
Si-Yang Li United States	18	819 1.3×	979 1.6×	416 1.9×	228 1.9×	79 0.8×	27	1.2k
Jasvir Dhillon United Kingdom	15	481 0.8×	571 0.9×	183 0.8×	163 1.4×	25 0.2×	17	710
Michelle S DeStefano United States	12	293 0.5×	358 0.6×	151 0.7×	111 0.9×	56 0.5×	20	532
Aurélie Chauffour France	18	804 1.3×	895 1.5×	335 1.5×	293 2.5×	78 0.8×	35	1.1k
André Trollip South Africa	15	817 1.3×	911 1.5×	202 0.9×	319 2.7×	43 0.4×	28	1.1k
Fengmin Huo China	19	697 1.1×	908 1.5×	224 1.0×	434 3.6×	69 0.7×	59	1.2k
Giulia Degiacomi Italy	15	386 0.6×	517 0.8×	426 1.9×	38 0.3×	151 1.5×	35	829

Countries citing papers authored by Tom Gevers

Since Specialization

Citations

This map shows the geographic impact of Tom Gevers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Gevers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Gevers more than expected).

Fields of papers citing papers by Tom Gevers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Gevers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Gevers. The network helps show where Tom Gevers may publish in the future.

Co-authorship network of co-authors of Tom Gevers

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Gevers. A scholar is included among the top collaborators of Tom Gevers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Gevers. Tom Gevers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lounis, Nacer, Luc Vranckx, Tom Gevers, Koné Kaniga, & Koen Andries. (2016). In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis. Médecine et Maladies Infectieuses. 46(4). 220–225. 17 indexed citations

Andries, Koen, Cristina Villellas, Nele Coeck, et al.. (2014). Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline. PLoS ONE. 9(7). e102135–e102135. 288 indexed citations

Rouan, M.C., Nacer Lounis, Tom Gevers, et al.. (2011). Pharmacokinetics and Pharmacodynamics of TMC207 and Its N -Desmethyl Metabolite in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 56(3). 1444–1451. 91 indexed citations

Andries, Koen, Tom Gevers, & Nacer Lounis. (2010). Bactericidal Potencies of New Regimens Are Not Predictive of Their Sterilizing Potencies in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 54(11). 4540–4544. 43 indexed citations

Rouan, M.C., Tom Gevers, Dirk Roymans, et al.. (2010). Pharmacokinetics-Pharmacodynamics of a Respiratory Syncytial Virus Fusion Inhibitor in the Cotton Rat Model. Antimicrobial Agents and Chemotherapy. 54(11). 4534–4539. 17 indexed citations

Roymans, Dirk, Hendrik L. De Bondt, Éric Arnoult, et al.. (2009). Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein. Proceedings of the National Academy of Sciences. 107(1). 308–313. 66 indexed citations

Lounis, Nacer, et al.. (2009). ATP Synthase Inhibition of Mycobacterium avium Is Not Bactericidal. Antimicrobial Agents and Chemotherapy. 53(11). 4927–4929. 40 indexed citations

Lounis, Nacer, et al.. (2008). Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model. Antimicrobial Agents and Chemotherapy. 52(10). 3568–3572. 50 indexed citations

Bonfanti, Jean‐François, Christophe Meyer, Jérôme Fortin, et al.. (2008). Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121). Journal of Medicinal Chemistry. 51(4). 875–896. 76 indexed citations

10.

Lounis, Nacer, et al.. (2008). Prevention of Drug Carryover Effects in Studies Assessing Antimycobacterial Efficacy of TMC207. Journal of Clinical Microbiology. 46(7). 2212–2215. 30 indexed citations

11.

Bonfanti, Jean‐François, Jérôme Fortin, Jérôme Guillemont, et al.. (2007). Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate, Part 1: Improving the Pharmacokinetic Profile Using the Structure−Property Relationship. Journal of Medicinal Chemistry. 50(19). 4572–4584. 37 indexed citations

12.

Andries, Koen, Marc Moeremans, Tom Gevers, et al.. (2003). Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus. Antiviral Research. 60(3). 209–219. 91 indexed citations

13.

Moeremans, M., et al.. (2001). R170591, a New Antiviral with picoMolar Activity against Respiratory Syncytial Virus.. Antiviral Research. 50(1). 76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact